Herbalzym

Bioavailable Parthenolide is a specific Histone Deacetylase (HDAC) Inhibitor, Part 2

September 27, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Parthenolide is the main extracts of sesquiterpene lactone isolated from medicinal herbs such as feverfew (Tanacetum parthenium). Sesquiterpene lactones (SLs) are plant-derived compounds often used in traditional medicine against inflammation and cancer. Sesquiterpene lactones (SLs) in clinical trials are artemisinin, thapsigargin and parthenolide and many of their synthetic derivatives. These drugs are selective toward tumor and cancer stem cells by targeting specific signaling pathways, which make them lead compounds in cancer clinical trials.

Parthenolide has been used conventionally to treat migraine and rheumatoid arthritis for centuries. Recently it has been reported that Parthenolide may induce inhibition of proliferation and apoptosis in various human cancer cells in vitro, such as colorectal cancer, pancreatic cancer, hepatoma, leukemia and cholangiocarcinoma.

In addition, Parthenolide can …

Bioavailable Parthenolide is a specific Histone Deacetylase (HDAC) Inhibitor, Part 1

September 26, 2010, Featured in Cancer and Natural Medicines, 0 Comments

The epigenetic control of gene expression has been shown to play a critical role in cancer initiation, progression, and resistance. Epigenetic regulation is most commonly controlled by a number of chemical modifications that alter the way DNA is packed, which in turn makes those genes easier to turn on or off. This natural pattern of activation, which is influenced by fetal environment, stress, diet, exercise and toxic exposure, among other things, is unique to each person. The three main types of epigenetic changes occur during epigenetic remodeling: 

DNA methylation can be mis-regulated during tumor formation, silencing tumor suppressor genes as well as other genes,
Histone modifications— including acetylation, Methylation, phosphorylation, ubiquitilation and sumoylation— are important in transcriptional regulation and many are stably maintained during cell division
Genomic imprinting is parent-of-origin-specific allele silencing, or …

Are we on the right TRAIL toward Death Receptor?

September 25, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Triggering of tumour cell apoptosis is the foundation of many cancer therapies. TRAIL (TNF-related apoptosis-inducing ligand) is a death pathway that, under the right circumstances, can induce cells to commit an orderly form of suicide called apoptosis. TRAIL (also known as Apo2L) is Type II transmembrane protein belonging to the Tumor Necrosis Factor (TNF) superfamily that is expressed on the surface of Natural Killer (NK) and T cells, macrophages and dendritic cells. As with other cytokines, the protein is synthesized in a pro-form with a signal sequence that is removed in the mature secreted protein.

Death receptors of TNF (the tumour necrosis factor) superfamily have been largely characterized, as have the signals that are generated when …

Induction of apoptosis by natural agents through mitochondrial cell death pathway, Part 4

September 22, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Apoptosis is a complex process, where important role is played by epigenetic mechanisms responsible for regulation of activity of proteins participating in this event. The presence of various forms of a given protein (as a result of alternative splicing) and post translation modification of protein molecules (phosphorylation, dephosphorylation, proteolytic cleavage) means that each protein can function as both proapoptotic and antiapoptotic factor. There are two major ways that could downregulate cancer cell apoptosis: (1) somatic and nonsomatic mutation and loss of expression of proapoptotic molecules; and (2) overexpression of apoptosis inhibitory molecules.

Some viruses associated with cancers use tricks to prevent apoptosis of the cells they have transformed. Several human papilloma viruses (HPV) have been implicated in causing cervical cancer. One of them produces a protein (E6) that binds and inactivates …

Induction of apoptosis by natural agents through mitochondrial cell death pathway, Part 3

September 22, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Mitochondrial fatty acid beta-oxidation is one of the main sources for energy production, particularly at times of stress or fasting. Fatty acids are oxidized inside the mitochondrial matrix but the fatty acids to be oxidized come from the cytosol. Fatty acids are activated in the cytosol by esterification with Coenzyme A (CoA) to form acyl-CoA (RCO-CoA, where R is the fatty acid acyl group).

Activated medium-chain fatty acids (C8 fatty acid and C10 fatty acid) freely diffuse into mitochondria to be oxidized but long chain fatty acids do not diffuse into mitochondria so they must be transported in. Palmitoylcarnitine is a well-known intermediate in mitochondrial fatty acid oxidation. The transport of long chain fatty acids into mitochondria for oxidation is accomplished by the carnitine palmitoyltransferase system (CPTI and CPTII). CPTI exchanges …

Induction of apoptosis by natural agents through mitochondrial cell death pathway, Part 2

September 20, 2010, Featured in Cancer and Natural Medicines, 0 Comments

It has long been known that calcium ions Ca(2+) signals govern a host of vital cell functions and so are necessary for cell survival. However, more recently it has become clear that cellular calcium ions Ca(2+) overload, or perturbation of intracellular Ca(2+) compartmentalization, can cause cytotoxicity and trigger either apoptotic or necrotic cell death.

Many cellular processes require proper cooperation between the plasma membrane, the nucleus and subcellular vesicular/tubular networks such as the ER (endoplasmic reticulum) and mitochondria. It has recently become clear that such contacts are crucial for the synthesis and intracellular transport of phospholipids as well as for intracellular Ca(2+) homeostasis, controlling fundamental processes like motility and contraction, secretion, cell growth, proliferation and apoptosis.

Altered metabolism is a feature of many diseases, as well as aging. The definition of this …

Induction of apoptosis by natural agents through mitochondrial cell death pathway, Part 1

September 19, 2010, Featured in Cancer and Natural Medicines, 0 Comments

A number of recent anti-cancer strategies aim at targeting the mitochondrial apoptotic machinery to induce tumor cell death. Apoptosis is a form of cell death in which a programmed sequence of events leads to the elimination of cells. The term apoptosis is derived from the Greek word that signifies the dropping of leaves from the trees. Apoptosis plays a crucial role in developing and maintaining health by eliminating old cells, unnecessary cells, and unhealthy cells. The human body replaces perhaps a million cells a second. Too little or too much apoptosis plays a role in a great many diseases. 

There is a distinct and precisely localized control over the fate of specific cells in a mixed cell population that undergo apoptosis. This event similar to proliferation is tightly regulated with both …

Cancer is a disease of abnormal cellular metabolism, Part 3

September 18, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Cancer cells need a lot of nutrients to multiply and survive. While much is understood about how cancer cells use blood sugar to make energy, not much is known about how they get other nutrients. Two related pathways are involved in cancer growth:

The insulin/insulin-like growth factor-1 (IGF1) signaling pathway, which is activated when nutrients are available,
The adenosine mono-phosphate-activated protein kinase (AMPK) pathway, activated when cells are starved for carbohydrates.

Gluconeogenesis (GNG) is a metabolic pathway that results in the generation of glucose from non-carbohydrate carbon substrates such as lactate, glycerol, and glucogenic amino acids. It is one of the two main mechanisms humans and many other animals use to keep blood glucose levels from dropping too low (hypoglycemia). The other means of maintaining blood glucose levels is through the degradation of …

Cancer is a disease of abnormal cellular metabolism, Part 2

September 17, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Cancer was formerly believed to be a localized disease, characterized by a lesion, usually in the form of a growth, which appeared at some specific part of the body. This localized lesion was thought to be the result of activity produced by an invading virus, carcinogenic agent, or some form of trauma. Today, there is a growing conviction that cancer is a complex disease that is the end result of a disturbed metabolism. The frequent recurrence of a malignancy after treatment with the conventional methods of surgery, radiation and/or chemotherapy results because the basic underlying metabolic cause of the cancer is rarely considered and consequently remains uncorrected.

In 2007, researchers at the University of Alberta, Canada, reported that DCA (dichloroacetate) has seemingly remarkable anticancer properties. DCA is a tiny molecule, odorless, …

Cancer is a disease of abnormal cellular metabolism, Part 1

September 17, 2010, Featured in Cancer and Natural Medicines, 0 Comments

Cancer cells are characterized by self-sufficiency in the absence of growth signals, their ability to evade apoptosis, resistance to anti-growth signals, sustained angiogenesis, uncontrolled proliferation, and invasion and metastasis. Alterations in cellular bioenergetics are an emerging hallmark of cancer.

Genome instability, leading to increased mutability, was considered the essential enabling characteristic for manifesting the hallmarks. However, the mutation rate for most genes is low making it unlikely that the numerous pathogenic mutations found in cancer cells would occur sporadically within a normal human lifespan. This then created a paradox. If mutations are such rare events, then how is it possible that cancer cells express so many different types and kinds of mutations? Mutations in each of cancer genes result in dysregulation of metabolic pathways involved in oxygen, iron, energy or nutrient …